GoodRx HoldingsGDRX
GDRX
About: GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Employees: 694
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
53% more call options, than puts
Call options by funds: $6.04M | Put options by funds: $3.95M
19% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 32
3.38% more ownership
Funds ownership: 140.72% [Q2] → 144.1% (+3.38%) [Q3]
1% more funds holding
Funds holding: 163 [Q2] → 165 (+2) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]
5% less capital invested
Capital invested by funds: $1.04B [Q2] → $986M (-$49.5M) [Q3]
21% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 47
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$6
31%
upside
Avg. target
$6.06
33%
upside
High target
$6.25
37%
upside
4 analyst ratings
3 positive
75%
1 neutral
25%
0 negative
0%
Citigroup Daniel Grosslight 39% 1-year accuracy 9 / 23 met price target | 37%upside $6.25 | Buy Maintained | 10 Jan 2025 |
Keybanc Scott Schoenhaus 17% 1-year accuracy 6 / 36 met price target | 31%upside $6 | Overweight Maintained | 8 Jan 2025 |
Morgan Stanley Craig Hettenbach 40% 1-year accuracy 2 / 5 met price target | 31%upside $6 | Equal-Weight Maintained | 17 Dec 2024 |
Barclays Stephanie Davis 38% 1-year accuracy 5 / 13 met price target | 31%upside $6 | Overweight Maintained | 11 Nov 2024 |
Financial journalist opinion
Based on 4 articles about GDRX published over the past 30 days
Neutral
PYMNTS
1 week ago
GoodRx CFO Karsten Voermann to Resign for Personal Reasons
GoodRx Holdings disclosed Monday (Jan. 13) that its chief financial officer, Karsten Voermann, submitted his resignation Tuesday (Jan. 7), effective Friday (Jan. 16). The company attributed the resignation to “personal reasons” in a Monday filing with the Securities and Exchange Commission.
Neutral
Business Wire
1 week ago
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California residents impacted by the wildfires devastating Los Angeles County. Starting today, Angelenos can use the code LA-GOODRX-CARE to be seen by a licensed medical provider on GoodRx Care for a variety of conditions. Hundreds of thousands of Californians have been impacted by the wildfires, which may p.
Neutral
Business Wire
1 week ago
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more affordable and convenient way for Americans to access pet medications. Through GoodRx for Pets, pet owners can find savings and have pet medications delivered right to their door. GoodRx for Pets provides a seamless experience for pet owners, combining convenience, affordability, and accessibility in one place.
Negative
CNBC
3 weeks ago
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health companies, around two-thirds have lost value this year, while the Nasdaq is up 32%.
Neutral
Business Wire
1 month ago
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time). A live webcast will be available on the Company's Investor Relations website, https://investors.
Neutral
Business Wire
1 month ago
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today revealed startling healthcare disparities in its new report, “Endocrinologist Deserts: A Critical Healthcare Gap for Millions in the U.S.” With nearly 70% of U.S. counties lacking an endocrinologist, the report paints a stark picture of the barriers millions of Americans face in managing life-threatening conditions like diabetes. The findings come at a critical time as the.
Neutral
Business Wire
1 month ago
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President and Chief Executive Officer, effective January 1, 2025. Wendy brings more than 30 years of leadership experience across the pharmacy and medical benefit industry to her new role. Wendy will join GoodRx following her role as CEO of RxBenefits, where she led the company in providing pharmacy benefit su.
Positive
CNBC
1 month ago
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Prescription fills for blockbuster weight loss medications in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments. That's according to new data from drug savings company GoodRx, which examined fill trends and spending patterns for weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
Neutral
Business Wire
1 month ago
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look at fill trends and spending patterns for weight loss medications across the U.S. The company found that limited insurance coverage and high out-of-pocket costs aren't slowing down interest in popular drugs used for weight loss such as Mounjaro, Ozempic, Wegovy, and Zepbound. In fact, some of these p.
Neutral
Business Wire
2 months ago
GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Helps, a 501(c)(3) nonprofit organization seeking to address health inequities across the country, has selected its 2024 Students for Healthcare Equity Scholarship recipients. The scholarship program was created to encourage culturally responsive healthcare by providing financial assistance to healthcare students from underrepresented groups. To date, GoodRx Helps has granted $325,000 in scholarships to students advocating for equitable access to he.
Charts implemented using Lightweight Charts™